Sulodexide Withdrawn Phase 4 Trials for Type 2 Diabetic Nephropathy Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03504566Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)